文献速递心境障碍儿童青少年精神

志愿者同伴递送思维健康计划干预围产期抑郁:巴基斯坦整群随机对照试验

Delivering the Thinking Healthy Programme for perinatal depression through volunteer peers: a cluster randomised controlled trial in Pakistan.
PubMed 文献 · Lancet Psychiatry · 2019-01-01

该研究在巴基斯坦拉瓦尔品第的40个村庄整群中,将WHO推荐的思维健康计划(THP)改编为志愿者同伴递送(THPP)联合强化常规照护,与单独强化常规照护比较。

要点

  • THPP对产后6个月抑郁严重度和缓解率无显著改善。
  • THPP在其他严重度和失能指标上显示有益且具成本效果。
  • THPP或可利用未开发人力资源缩小围产期抑郁治疗缺口。

核心结论

  • THPP对产后6个月围产期抑郁症状严重度和缓解率无显著效果。
  • THPP在其他严重度和失能指标上有益且具有成本效果。

研究设计与样本

  • 在巴基斯坦拉瓦尔品第开展整群随机对照试验,40个村庄整群按1:1随机分配。
  • 干预组接受THPP联合强化常规照护,对照组仅接受强化常规照护。
  • 参与者为18岁及以上、PHQ-9评分至少10分的孕妇,从社区家庭中招募。
  • 主要结局为产后6个月PHQ-9抑郁严重度和缓解率(PHQ-9<5),按意向治疗分析。

主要发现

  • 产后6个月,干预组227人(80%)和对照组226人(79%)完成主要结局评估。
  • 两组间严重不良事件无显著差异证据。

临床怎么用

  • THPP不作为改善产后6个月抑郁严重度或缓解率的有效干预。
  • THPP可能在其他严重度和失能指标上带来益处且具成本效果,可考虑作为利用志愿者同伴资源缩小治疗缺口的策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Thinking Healthy Programme (THP), which is endorsed by WHO, is an evidence-based intervention for perinatal depression. We adapted THP for delivery by volunteer peers (laywomen from the community) to address the human resource needs in bridging the treatment gap, and we aimed to assess its effectiveness and cost-effectiveness in Rawalpindi, Pakistan. METHODS: In this cluster randomised controlled trial, we randomly assigned 40 village clusters (1:1) to provide either THP peer-delivered (THPP) and enhanced usual care (EUC; intervention group) or EUC only (control group) to the participants within clusters. These villages were randomly selected from eligible villages by an independent researcher. The participants were pregnant women aged 18 years or older who had scored at least 10 on the Patient Health Questionnaire-9 (PHQ-9), who we recruited from households within communities in Rawalpindi, Pakistan. The research teams who were responsible for recruiting trial participants were masked to treatment allocations. Participants attended follow-up visits at 3 and 6 months after childbirth. The primary outcomes were the severity of depressive symptoms (assessed by PHQ-9 score) and the prevalence of remission (defined as a PHQ-9 score of less than 5) in participants with available data 6 months after childbirth, which was assessed by researchers who were masked to treatment allocations. We analysed outcomes by intention to treat, adjusting for covariates that were defined a priori or that showed imbalance at baseline. The trial was registered with ClinicalTrials.gov, number NCT02111915. FINDINGS: Between April 15 and July 30, 2014, we randomly selected 40 of 46 eligible village clusters for assessment, as per sample size calculations. Between Oct 15, 2014, and Feb 25, 2016, we identified and screened 971 women from 20 village clusters that had been randomly assigned to the THPP and EUC group and 939 women from 20 village clusters that had been randomly assigned to the EUC only group. In the intervention group, 79 women were ineligible for inclusion, 11 women refused screening, 597 women screened negative on the PHQ-9, and one woman did not consent to participate. In the control group, 75 women were ineligible for inclusion, 14 women refused screening, 562 women screened negative on the PHQ-9, and one woman did not consent to participate. We enrolled 283 (29%) women in the intervention group and 287 (31%) women in the control group. At 6 months after childbirth, 227 (80%) women in the THPP and EUC group and 226 (79%) women in the EUC only group were assessed for the primary outcome. The severity of depression (assessed by PHQ-9 scores; standardised mean difference -0·13, 95% CI -0·31 to 0·06; p=0·07) and prevalence of remission (49% in the intervention group vs 45% in the control group; prevalence ratio 1·12, 95% CI 0·95 to 1·29; p=0·14) did not significantly differ between the groups 6 months after childbirth. There was no evidence of significant differences in serious adverse events between the groups. INTERPRETATION: THPP had no effect on symptom severity or remission from perinatal depression at 6 months after childbirth, but we found that it was beneficial on some other metrics of severity and disability and that it was cost-effective. THPP could be a step towards use of an unused human resource to address the treatment gap in perinatal depression. FUNDING: National Institute of Mental Health (USA).

来源:Lancet Psychiatry,查看原文。版权归原作者所有。

引用

  1. Sikander S, Ahmad I, Atif N, et al. Delivering the Thinking Healthy Programme for perinatal depression through volunteer peers: a cluster randomised controlled trial in Pakistan. Lancet Psychiatry. 2019. PMID: 30686386. doi:10.1016/S2215-0366(18)30467-X

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。